一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Science >>article
Advanced Science

Advanced Science

IF: 14.3
Download PDF

Cinobufagin Directly Targets PDE4D to Disrupt Fibroblast–Dendritic Cell Crosstalk in Atopic Dermatitis

Published:8 October 2025 DOI: 10.1002/advs.202501670 PMID: 41059955
Shicong Li,?Dihui Xu,?Chenyang Zhang,?Chunxiu Xiao,?Meng Yu,?Jiaojiao Wang,?Wenyuan Wu,?Xiang Lv,?Dongping Yuan,?Liang Zhang,?Min Hong,?Jing Zhou,?Yang Sun,?Hongyue Ma,?Yuyu Zhu

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease driven by immune dysregulation and Th2-dominant inflammation. This study identifies phosphodiesterase 4D (PDE4D) as a key regulator of AD pathogenesis and a potential therapeutic target. Single-cell RNA sequencing (scRNA-seq) revealed activation of the macrophage migration inhibitory factor (MIF) signaling pathway in lesional tissues, with inflammatory fibroblasts mediating MIF-driven interactions with myeloid cells. Elevated PDE4D expression in lesional tissues suppressed cyclic adenosine monophosphate (cAMP) signaling, promoting inflammation. Cinobufagin, a bufadienolide compound, is identified as a potent PDE4D inhibitor. Compared to other PDE4 inhibitors used in clinical cases, cinobufagin demonstrated superior efficacy in improving AD in mice while effectively regulating the MIF pathway. It directly bound to PDE4D, restored cAMP signaling, suppressed MIF secretion in inflammatory fibroblasts, and disrupted fibroblast-dendritic cell interactions via the cAMP/protein kinase A (PKA)/cAMP-response element binding protein (CREB) pathway, thereby significantly reducing the clinical and histological features of AD. Notably, PDE4D knockout mice exhibited diminished inflammation, mimicking the effects of cinobufagin and confirming a role for PDE4D in AD progression. These findings establish PDE4D as a critical driver of AD and demonstrate that cinobufagin effectively targets this pathway, offering a promising therapeutic approach for AD and related inflammatory skin disorders.

Similar articles

IF:2.9

Baricitinib for the treatment of atopic dermatitis.

Journal of Dermatological Treatment Amelia Melo, Jose Manuel Carrascosa,etc Published: 1 August 2022
IF:0

Efficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label study

Indian Journal of Skin Allergy Abhishek De, Disha Chakraborty,etc Published: 12 February 2024
灵川县| 贵定县| 柳林县| 鲜城| 盈江县| 临海市| 昌乐县| 资阳市| 自贡市| 双牌县| 巢湖市| 积石山| 盈江县| 晴隆县| 积石山| 临武县| 常宁市| 巫山县| 二手房| 措勤县| 吴江市| 芦山县| 宁晋县| 雅江县| 富川| 麻江县| 综艺| 龙泉市| 奉新县| 湛江市| 罗江县| 金沙县| 皮山县| 莫力| 利辛县| 岳西县| 安仁县| 漳州市| 苍南县| 福贡县| 成武县|